Literature DB >> 21130005

Functional ability in patients with critical limb ischaemia is unaffected by successful revascularisation.

E Cieri1, M Lenti, P De Rango, G Isernia, A Marucchini, P Cao.   

Abstract

OBJECTIVE: Patient- and society-oriented measures of outcome have a critical role in determining the effectiveness of any treatment in patients with critical limb ischaemia (CLI). In particular, the impact of an intervention on patient's dependency and functional performance is relevant but is largely unknown. The aim of the study was to investigate whether the limitations encountered in the activities of daily living (ADLs) measured with the Katz Index (KI) in patients with CLI were changed by the treatment.
METHODS: During the period 2006-2008, 248 consecutive patients undergoing repair for CLI were investigated with an ADL questionnaire for assessing KI before and after a mean of 16.19 months from treatment. Changes in KI were stratified by type of treatment and outcome.
RESULTS: There were 165 males and 83 females, mean age 73.3 ± 8.3 years; 125 patients showed tissue loss and 123 rest pain alone, 98 received surgical bypass and 150 endovascular repair. Pre-operative KI mean was 10.42. At the post-operative assessment, there was significant worsening in patients' functional outcome (mean KI decreased to 9.78) despite relief of pain (81.5%), tissue healing (72%), good vessel patency (83.8%) and low amputation rate (9.7%). Deterioration of KI was not significantly higher in patients undergoing endovascular repair. Patients receiving major amputation started with worse pre-operative functional score (KI mean 9.42) and did further deteriorate (KI mean 7.71) after demolition surgery. However, patients who received successful revascularisation showed deterioration in the dependence index.
CONCLUSIONS: Successful vascular treatment is not associated with improved functional ability in patients with CLI, especially when already highly dependent in their activities. Large nationwide preventive and educational programmes should be implemented to prevent irreversible and severe health deterioration in populations with CLI.
Copyright © 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21130005     DOI: 10.1016/j.ejvs.2010.10.014

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  11 in total

1.  Management of critical lower limb ischemia in endovascular era: experience from 511 patients.

Authors:  Baker Ghoneim; Hussein Elwan; Waleed Eldaly; Hussein Khairy; Ahmad Taha; Amr Gad
Journal:  Int J Angiol       Date:  2014-09

2.  Objective measurement of lower extremity function and quality of life after surgical revascularization for critical lower extremity ischemia.

Authors:  Gregory J Landry; Nick O Esmonde; Jason R Lewis; Amir F Azarbal; Timothy K Liem; Erica L Mitchell; Gregory L Moneta
Journal:  J Vasc Surg       Date:  2014-03-07       Impact factor: 4.268

3.  One year clinical outcomes of Rutherford 6 chronic limb threatening ischemia patients undergoing lower limb endovascular revascularisation from Singapore.

Authors:  Rui En Lee; Ankur Patel; Shereen Xue Yun Soon; Sze Ling Chan; Charyl Jia Qi Yap; Sivanathan Chandramohan; Luke Hsien Ts'ung Tay; Tze Tec Chong; Tjun Yip Tang
Journal:  CVIR Endovasc       Date:  2022-07-06

4.  Toll-like receptors in ischaemia and its potential role in the pathophysiology of muscle damage in critical limb ischaemia.

Authors:  Hemanshu Patel; Sidney G Shaw; Xu Shi-Wen; David Abraham; Daryll M Baker; Janice C S Tsui
Journal:  Cardiol Res Pract       Date:  2012-02-07       Impact factor: 1.866

5.  TLR-4 and CD14 Genotypes and Soluble CD14: Could They Predispose to Coronary Atherosclerosis?

Authors:  Maria Kalliopi Konstantinidou; Nikos Goutas; Dimitrios Vlachodimitropoulos; Antigoni Chaidaroglou; Demetrios Stefanou; Nikoleta Poumpouridou; Renata Mastorakou; Maria Gazouli; Dimitrios Kyparissopoulos; Chara Spiliopoulou
Journal:  J Cardiovasc Dev Dis       Date:  2016-03-10

6.  Serum-derived extracellular vesicles (EVs) impact on vascular remodeling and prevent muscle damage in acute hind limb ischemia.

Authors:  Claudia Cavallari; Andrea Ranghino; Marta Tapparo; Massimo Cedrino; Federico Figliolini; Cristina Grange; Valentina Giannachi; Paolo Garneri; Maria Chiara Deregibus; Federica Collino; Pietro Rispoli; Giovanni Camussi; Maria Felice Brizzi
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

7.  Validation of the Risk Score of the Mortality and Lower Limb Loss Considering Ambulatory Status after Surgical Revascularization in Maintaining Patients with Dialysis.

Authors:  Haruto Yamazaki; Hisae Hayashi; Morio Kawamura; Ayana Sasaki; Eriko Kondo; Shinya Ito; Kenji Wakai
Journal:  Ann Vasc Dis       Date:  2017-09-25

8.  Anthropometric and Quality-of-Life Parameters in Acute Intermittent Porphyria Patients.

Authors:  Antonia M Jiménez-Monreal; MAntonia Murcia; Victoria Gómez-Murcia; Maria Del Mar Bibiloni; Antoni Pons; Josep A Tur; Magdalena Martínez-Tomé
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

9.  Unacylated ghrelin promotes skeletal muscle regeneration following hindlimb ischemia via SOD-2-mediated miR-221/222 expression.

Authors:  Gabriele Togliatto; Antonella Trombetta; Patrizia Dentelli; Paolo Cotogni; Arturo Rosso; Matthias H Tschöp; Riccarda Granata; Ezio Ghigo; Maria F Brizzi
Journal:  J Am Heart Assoc       Date:  2013-12-05       Impact factor: 5.501

10.  Important differences between quality of life and health status in elderly patients suffering from critical limb ischemia.

Authors:  Stijn L Steunenberg; Jolanda de Vries; Jelle W Raats; Nathalie Verbogt; Paul Lodder; Geert-Jan van Eijck; Eelco J Veen; Hans Gw de Groot; Gwan H Ho; Lijckle van der Laan
Journal:  Clin Interv Aging       Date:  2019-07-08       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.